EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
Tags :Alex Nikitine
Walder Wyss has acted as legal counsel to Swisscanto Invest by Zürcher Kantonalbank in connection with the series B financing round of Sulzer & Schmid Laboratories, an independent Swiss technology company of next-generation technology
Walder Wyss acted as counsel to Credit Suisse and UBS as Joint Global Coordinators and Joint Bookrunners in the Rights Offering of Swiss Steel Holding (read here all the advisors).
The team is being led by Alex Nikitine (Partner, Corporate/M&A, Capital Markets - pictured) and further includes Rafael Zemp (Managing Associate, Corporate/M&A, Capital Markets), Christian Lütolf (Associate, Corporate/M&A),
The Walder Wyss team has been led by Alex Nikitine (Partner, Corporate/M&A - pictured ) and included Thiemo Sturny (Partner, Corporate/M&A), Dimitrios Berger (Associate, Corporate/M&A) and Hugh Reeves (Senior Associate,
The team is being led by Alex Nikitine (Partner, Corporate/M&A, Capital Markets - pictured) and further includes Rafael Zemp (Managing Associate, Corporate/M&A, Capital Markets), Christian Lütolf (Managing Associate, Corporate/M&
Walder Wyss advised ANYbotics in connection with this transaction. The team was led by Alex Nikitine (Partner, Corporate/M&A - pictured left). MLL advised Swisscom Ventures. The team was led by Karin Oberlin (Partner,
The Walder Wyss team has been led by Alex Nikitine (Partner, Corporate/M&A - pictured) and included Thiemo Sturny (Partner, Corporate/M&A), Dimitrios Berger (Associate, Corporate/M&A), Hugh Reeves (Senior Associate, IP/
Walder Wyss acted as Swiss counsel to CRISPR in connection with the transaction. The team was led by partner Alex Nikitine. Homburger acted as legal counsel to Goldman Sachs & Co. LLC, BofA Securities, Inc. and
Walder Wyss advised the sellers in this transaction. The team was led by partner Alex Nikitine (corporate/m&a - pictured) and senior associate Marion Bähler (corporate/m&a)
